Revelation Biosciences Inc
REVB
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.16M
Close$
$1.60
57.7% downside
Current Fair Value
57.7% downsideOvervalued by 57.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.16 Million |
|---|---|
| Enterprise Value | $-8,586,142.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-167.65 |
| Beta | -0.17 |
| Outstanding Shares | 547,052 |
Return
| Return on Equity | -147705.72% |
|---|---|
| Return on Assets | -118975.80% |
| Return on Invested Capital | -139968.33% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | -0.22 |
| Price to Sales | - |
| Price to Book Ratio | 0.21 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$-6.13
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-6.16
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Revelation Biosciences Inc
2 employees